Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Cel-Sci Corporation Common Stock ($0.001 Par Value) Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 0.5599||$ 1.03|
|Low||$ 0.55||$ 0.36|
The current last sale of $0.55 is 52.78% Higher thanthe 52 week low.
Company Description (as filed with the SEC)
CEL-SCI is focused on finding the best way to activate the immune system to fight cancer and infectious diseases. CEL-SCI believes that the best results can be achieved by giving its cancer immunotherapy drug before surgery, radiation and chemotherapy, at a time when the immune system is much stronger. Other cancer immunotherapies are typically given after these conventional treatments. CEL-SCI's lead investigational therapy Multikine® (Leukocyte Interleukin, Injection) is currently in a pivotal Phase 3 clinical trial against advanced primary (not yet treated) head and neck cancer, for which CEL-SCI has received Orphan Drug Status from the U.S. FDA. If the primary endpoint of the FDA study is achieved, the results will be used to support applications to regulatory agencies around the world for worldwide commercial marketing approvals as a first line cancer therapy. ... More ...
Where does CVM fit in the risk graph?
|Annual EPS Est:||$|
|Quarterly EPS Est:|